Key result
Thoracic MRI evaluates mediastinal mature cystic teratomas more definitively than CT via superior tissue characterization.
Case Report (n=3)
Thoracic MRI offers superior tissue characterization for evaluating mediastinal mature cystic teratomas compared to CT.
May support selective MRI use for mediastinal teratoma characterization; hypothesis-generating and should not yet change practice.
Mature cystic teratoma (MCT) is a benign, slow-growing tumor and accounts for approximately 75% of mediastinal germ cell tumors. Patients with MCT are often asymptomatic when the tumors are small. Most of the symptoms are frequently related to compression of the mediastinal structures. We herein describe 3 adult cases of MCT. The patients were a 37-year-old man, a 35-year-old woman, and a 54-year-old woman. They were hospitalized with compression-related symptoms, such as chest pain, dyspnea, and cough. Findings from conventional chest radiograph, computed tomography (CT), magnetic resonance imaging were characterized. Conventional chest radiography still plays a major role in the initial evaluation of MCT, while CT remains the preferred modality for initial cross-sectional imaging evaluation of mediastinal lesions. However, thoracic magnetic resonance imaging provides more detailed and often definitive evaluation of mediastinal masses than CT because of its superior tissue characterization.
No takes yet. Share an insight, caveat, or question.
Duc et al. (2020) conducted a case report in Mediastinal mature cystic teratoma (n=3). Imaging evaluation (chest radiograph, CT, MRI) was evaluated on Imaging findings characterization. Thoracic magnetic resonance imaging provided more detailed and definitive evaluation of mediastinal mature cystic teratomas than computed tomography due to its superior tissue characterization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: